Xeltis: Valuation, Funding & Investors
Xeltis is a pioneering medical technology company specializing in the development of transformative bioresorbable vascular implants. These innovative implants facilitate the natural formation of living and durable blood vessels, offering a groundbreaking solution in the field of cardiovascular health. Based in Eindhoven, Netherlands, Xeltis is at the forefront of advancing vascular health through its cutting-edge technology.
Leadership & Board
- Current Number of Employees
- 84
- Current LinkedIn Followers
- 10,224
Latest Estimated Valuation
- Total Amount Raised
- $74M
- Total Funding Rounds
- 3
- Latest Funding Amount
- $50M
- Latest Funding Round
- Investment
Company Momentum Positive
Xeltis LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Xeltis had 84 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Xeltis had 10,224 followers as of October 26, 2026. The number of followers increased by 54 (0.53%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 02, 2025 | Investment | $50.00M | ― |
| Apr 08, 2025 | Investment | $10.00M | ― |
| Sep 14, 2023 | Series D | $13.60M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| DaVita Venture Group | Investment |
| EQT Life Sciences | Investment |
| Invest-NL | Investment |
| European Innovation Council | Investment (2) |
| Kurma Partners | Investment |
| Ysios Capital | Investment |
| European Investment Bank | Investment |
| VI Partners | Investment |
Similar Companies
A snapshot of private companies similar to Xeltis, helping you discover and navigate related company profiles.
Related News and Analysis
